Peptide therapeutics have progressed from insulin discovery to GLP-1 class molecules, revolutionizing diabetes treatment and beyond. Peptide manufacturing capacity is projected to grow significantly, ...
The two companies enter into a multi-year strategic agreement to accelerate drug development timelines, strengthen U.S. manufacturing capabilities and help bring lifesaving medicines to patients ...
BioDuro, a research and CDMO group, opened a new peptide synthesis manufacturing facility at its campus in the Zhangjiang tech center in Shanghai. The facility expands the company’s peptide synthesis ...
Novo Nordisk is spending $6 billion in Kalundborg, Denmark, to expand the production of active pharmaceutical ingredients (APIs), including peptides used in weight-loss and antidiabetic drugs. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback